Government bodies, biobanks and non-profits at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
33 government bodies, biobanks and non-profits are at FoG London 2027 — 41 presentations on the program and 13 with a booth in the exhibit hall. Most represented: Our Future Health (5 on the program), Genomics England (4 on the program), NIHR BioResource (3 on the program). 21 of them have their own page in this guide. As of Oct 29, 2026.
Topic
Top represented
Showing 1–12 of 33 organizations
| Organization | FoG London 2027 Attendance |
|---|---|
UK health research programme recruiting millions of adult volunteers who share health data and blood samples to study prevention and early detection. | Booth Exhibiting at Booth 106B Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 14:30–15:00 From Risk Prediction to Precision Prevention How large population cohorts let researchers study disease risk before symptoms appear, to find biomarkers and build evidence for prevention. Talk Wed Jan 27 14:30–16:00 Trust in the Data Age: Who Should Access Our Genomic Data and Why? Biodata & bioinformaticsPopulation & social genomics Talk Thu Jan 28 12:00–12:30 Finding The Right Participants For The Right Research How matching people by clinical, genetic or risk profile to suitable studies could speed recruitment for precision clinical research. |
Genomics England London, UK | |
Government-owned company providing whole-genome sequencing for the NHS Genomic Medicine Service and research, including the Generation newborn study. | Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 14:30–15:00 The Generation Study: Insights From a National Study of Newborn Genome Sequencing What a national study sequencing newborn genomes has learned so far about recruitment and results, and what it means for newborn screening. Talk Thu Jan 28 14:40–15:10 The Genomics England Adult Population Programme How Genomics England is designing a genomics programme for the adult population, what public engagement has taught, and its future plans. |
NIHR BioResource Cambridge, UK | |
National panel of volunteers, with and without health conditions, who give samples and data and can be recalled for research studies. | Booth Exhibiting at Booth 108 Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 12:30–13:00 What We've Been Missing: Unlocking New Discoveries Through Large-Scale Long-Read Sequencing How large-scale long-read sequencing, which reads long DNA stretches, uncovers hidden genome regions, with early findings in mental health and rare disease. Genomic medicine & rare disease Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 14:30–16:00 Trust in the Data Age: Who Should Access Our Genomic Data and Why? Biodata & bioinformaticsPopulation & social genomics |
National body leading the NHS in England, including the NHS Genomic Medicine Service and national genomic testing. | Talk Wed Jan 27 09:00–09:30 The Next Chapter of Genomic Medicine How genomics is being built into everyday care nationally, and the staff, systems and partnerships it will take to scale up. Genomic medicine & rare disease Talk Wed Jan 27 16:30–17:00 NHS Genomics Data & Digital: Progress Towards a More Connected Genomic Medicine Service What the NHS genomics data programme changed this past year, from test ordering to moving genomic results between services, and what comes next. Talk Wed Jan 27 17:00–17:30 One Patient, One Genomic Record: Making Genomics Work Across the NHS How the NHS plans to record each patient's genomic results once and share them with clinicians, using data from 26 genomic laboratories. Talk Thu Jan 28 16:10–17:10 UK Healthcare Updates Genomic medicine & rare disease |
UK Biobank Stockport, UK | |
Research resource holding genetic, proteomic, imaging and health record data from 500,000 UK volunteers for approved researchers worldwide. | Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics Talk Wed Jan 27 11:30–12:00 Talk Wed Jan 27 14:30–15:00 Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources? Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust. Talk Wed Jan 27 15:30–16:00 Population Proteomics at Scale: How UK Biobank Is Transforming Drug Discovery and Precision Medicine How measuring proteins across the UK Biobank population, combined with genetic and clinical data, helps uncover biomarkers and new drug targets. Also |
Health Data Research UK London, UK | |
UK national institute for health data science; leads programmes such as DARE UK on secure, federated access to health data. | Talk Wed Jan 27 15:30–16:00 Streamlining and Accelerating Health Data Discovery and Access How UK services help researchers find and request health data, vet who may use it, and build shared tools once for reuse. Talk Wed Jan 27 17:30–18:00 Enhancing TRE Capabilities to Support Federation and AI Projects: the Experience of DARE UK How the UK's more than 60 secure research environments, where sensitive data never leaves, could be linked up and support AI projects safely. |
M MHRA London, UK | |
UK regulator of medicines and medical devices, including clinical trial and marketing approvals for advanced therapies. | Talk Thu Jan 28 14:10–14:40 De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients How advanced cell and gene therapies could reach patients sooner through smarter trials, a new law allowing on-site manufacturing, and fairer research. Talk Thu Jan 28 16:40–17:10 Navigating MHRA Guidelines and Clinical Trial Regulations for ATMPs How to apply to the UK medicines regulator for a clinical trial of an advanced cell or gene therapy, with practical tips. |
Public Health Wales Cardiff, UK | |
National public health agency for Wales, running screening programmes, including newborn screening, and health protection services. | Talk Wed Jan 27 15:00–15:30 A Multi-Omic and Ethical Framework for Newborn Screening in Wales How Wales pairs metabolic tests with genomics in newborn screening, puts each baby's benefit first, and tests genome sequencing from dried blood spots. Talk Thu Jan 28 12:30–13:00 Could Polygenic Risk Scores Transform Preventive Health in Wales? Whether polygenic risk scores, which combine many small genetic effects, could add to NHS health checks in Wales to spot hidden disease risk. |
NHS Wales body advising on access to medicines, their safe and effective use, and poisons information. | Talk Thu Jan 28 11:30–12:00 Building System Readiness for Disruptive Medicines in Wales How Wales is preparing its health service for new precision medicines, planning 6–12 months before national approval guidance to meet a 60-day access target. |
ELIXIR Hinxton, UK | |
Intergovernmental organisation coordinating life science data resources and infrastructure across European countries, including federated human genomics data. | Talk Wed Jan 27 12:30–13:00 Building Europe’s Federated Genomics Infrastructure: From Technical Foundations to Data at Scale How European projects are linking national genomic data services so researchers can securely find and analyse sensitive data across countries. |
UK national service, backed by government and Wellcome, set up to give researchers a single route to NHS health data. | Talk Wed Jan 27 10:00–10:20 Unlocking the UK's Health Data Potential: The Vision and Future of HDRS What the UK's national health data research service learned in its first year, and how it plans to simplify health data research. Biodata & bioinformatics Panel Wed Jan 27 10:20–11:00 The UK's Health Data Advantage: Powering the Future of Life Sciences What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery. Biodata & bioinformatics |
Cell and Gene Therapy Catapult London, UK | |
Independent UK innovation and technology organisation supporting the development, manufacture and adoption of cell and gene therapies. | Booth Exhibiting at Booth 15 Talk Thu Jan 28 12:30–13:00 The Acceleration of Therapies from Diagnosis to Delivery How genomic diagnosis is opening the way to personalised treatments, and what UK treatment centres have learned about getting advanced therapies to patients. |
Find buyers from government bodies, biobanks and non-profits
Tell us what you sell and we’ll find the people at these government bodies, biobanks and non-profits most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse FoG London 2027 by
Organization type
Topic
- Genomic medicine & rare disease 54
- Cancer genomics & diagnostics 31
- AI in drug discovery & diagnostics 43
- Biodata & bioinformatics 33
- Single-cell genomics 24
- Spatial biology 19
- Multi-omics & proteomics 31
- Epigenetics & translational omics 16
- Pharmacogenomics & patient stratification 16
- Women’s and children’s health 13
- Cell & gene therapy 18
- Microbiome & pathogen genomics 17
- Plant & agricultural genomics 13
- Population & social genomics 23
Exhibit hall
Everyone
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction